Caring Brands (CABR) Payables (2024 - 2026)
Caring Brands (CABR) posted quarterly Payables of $373020.0 for Q1 2026, up 118.97% quarter-over-quarter from $170351.0 in Q4 2025.
Caring Brands (CABR) Payables (2024 - 2026) Analysis & Trends
Caring Brands' Payables history runs 3 years deep, the most recent figure standing at $373020.0 for Q1 2026.
- In Q1 2026, Payables changed N/A year-over-year to $373020.0; the TTM figure through Mar 2026 stood at $373020.0 (changed N/A YoY), while the FY2025 annual figure was $170351.0, up 0.54% from the prior year.
- Payables for Q1 2026 stood at $373020.0, up from $170351.0 in the prior quarter.
- The five-year high for Payables was $373020.0 in Q1 2026, with the low at $169432.0 in Q4 2024.
- The 3-year median for Payables is $258937.5 (2025), against an average of $265081.8.
- Peak annual rise in Payables reached 0.54% in 2025, while the deepest fall reached 0.54% in 2025.
- Caring Brands' Payables stood at $169432.0 in 2024, then rose by 0.54% to $170351.0 in 2025, then soared by 118.97% to $373020.0 in 2026.
- Business Quant data shows CABR's Payables at $373020.0 in Q1 2026, $170351.0 in Q4 2025, and $347524.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.07 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.51 Bn | 30.83 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 19.01 Bn | 18.13 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 986.00 Mn |
| 10 | Caring Brands | 12.40 Mn | 10.58 Mn | - | 293,805.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 293,805.00 |
| Mar 31, 2026 | 373,020.00 |
| Dec 31, 2025 | 170,351.00 |
| Sep 30, 2025 | 347,524.00 |
| Dec 31, 2024 | 169,432.00 |